The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway
about
A broad role for the zinc finger protein ZNF202 in human lipid metabolismCharacterization of the human ABCG1 gene: liver X receptor activates an internal promoter that produces a novel transcript encoding an alternative form of the proteinABCA1 and scavenger receptor class B, type I, are modulators of reverse sterol transport at an in vitro blood-brain barrier constituted of porcine brain capillary endothelial cellsThe ABCA1 transporter modulates late endocytic trafficking: insights from the correction of the genetic defect in Tangier diseasePurification of ATP-binding cassette transporter A1 and associated binding proteins reveals the importance of beta1-syntrophin in cholesterol effluxLXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytesBlasts from the pastPPARgamma1 and LXRalpha face a new regulator of macrophage cholesterol homeostasis and inflammatory responsiveness, AEBP1Ceramide stimulates ABCA12 expression via peroxisome proliferator-activated receptor {delta} in human keratinocytesControl of cellular cholesterol efflux by the nuclear oxysterol receptor LXR alphaDistribution of brevetoxin (PbTx-3) in mouse plasma: association with high-density lipoproteins.High density lipoproteins: Measurement techniques and potential biomarkers of cardiovascular riskAnti-atherogenic mechanisms of high density lipoprotein: effects on myeloid cellsThe Structure of Dimeric Apolipoprotein A-IV and Its Mechanism of Self-AssociationLXR-mediated activation of macrophage stearoyl-CoA desaturase generates unsaturated fatty acids that destabilize ABCA1Cathepsin D, a lysosomal protease, regulates ABCA1-mediated lipid effluxSAA does not induce cytokine production in physiological conditionsABCA1 overexpression leads to hyperalphalipoproteinemia and increased biliary cholesterol excretion in transgenic miceMonocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levelsMonogenic dyslipidemias: window on determinants of plasma lipoprotein metabolismSPTLC1 binds ABCA1 to negatively regulate trafficking and cholesterol efflux activity of the transporterLRP1 controls cPLA2 phosphorylation, ABCA1 expression and cellular cholesterol exportABCA12 maintains the epidermal lipid permeability barrier by facilitating formation of ceramide linoleic estersWhole-genome survey of the putative ATP-binding cassette transporter family genes in Vitis viniferaSterol regulatory element-binding protein-2- and liver X receptor-driven dual promoter regulation of hepatic ABC transporter A1 gene expression: mechanism underlying the unique response to cellular cholesterol statusIdentification and characterization of rodent ABCA1 in isolated type II pneumocytesProteomic and metabolomic analyses of mitochondrial complex I-deficient mouse model generated by spontaneous B2 short interspersed nuclear element (SINE) insertion into NADH dehydrogenase (ubiquinone) Fe-S protein 4 (Ndufs4) geneIntracellular lipidation of newly synthesized apolipoprotein A-I in primary murine hepatocytesRole of the C terminus of the photoreceptor ABCA4 transporter in protein folding, function, and retinal degenerative diseases.Enlargement of high density lipoprotein in mice via liver X receptor activation requires apolipoprotein E and is abolished by cholesteryl ester transfer protein expression.Novel approaches to treating cardiovascular disease: lessons from Tangier disease.ABCA1, ABCG1 and SR-BI: hormonal regulation in primary rat hepatocytes and human cell linesIbrolipim increases ABCA1/G1 expression by the LXRα signaling pathway in THP-1 macrophage-derived foam cells.Thiazolidinedione-independent activation of peroxisome proliferator-activated receptor γ is a potential target for diabetic macrovascular complications.Prelesional arterial endothelial phenotypes in hypercholesterolemia: universal ABCA1 upregulation contrasts with region-specific gene expression in vivoReverse cholesterol transport pathway in experimental chronic renal failure.Reduction in dietary omega-6 polyunsaturated fatty acids: eicosapentaenoic acid plus docosahexaenoic acid ratio minimizes atherosclerotic lesion formation and inflammatory response in the LDL receptor null mouse.Increased serum triglyceride clearance and elevated high-density lipoprotein 2 and 3 cholesterol during treatment of primary hypertriglyceridemia with bezafibrate.Humans with atherosclerosis have impaired ABCA1 cholesterol efflux and enhanced high-density lipoprotein oxidation by myeloperoxidase.ABC1: connecting yellow tonsils, neuropathy, and very low HDL.
P2860
Q22253447-18991453-A581-4B2D-8F64-6F3B68C1BD31Q24291555-9CDBC79D-4FF4-4EA7-83D6-29B01F6268B6Q24305511-B28E51FF-CD60-4AEA-9270-A105C9AEED89Q24306475-9F7A5BE5-5720-4E7E-AB48-D9EECC3A0C09Q24337138-3AFA9AF9-6A33-423F-B54B-7DBC4040814BQ24548189-228F82A1-5E1B-4823-A255-4852F35C5438Q24563415-EFDF6661-1391-4DE3-B979-42C80EFDFDB5Q24633440-AEAF9860-BC8A-4374-A963-AA3F8D4401ECQ24651375-13FF8436-560B-485F-8B65-C187C2E11A67Q24683359-E85C9D2C-F695-4E86-82AE-023FC22C5ECEQ24810747-F02A478A-513C-4341-9D59-573D637F06F6Q26775420-BCCF0090-DBEA-4F0F-A976-BB5BCA9B4531Q27012536-749DCD47-BD50-455C-8A7B-8F81E5115C35Q27679028-CB1D9F38-5377-4A73-A3E1-4196966C7BAFQ28245597-C7D6BA9B-64C7-4E39-878A-DC34F3938F88Q28267787-7DADDF9D-58B4-4EEB-A753-2A56D9B43F55Q28279562-4CE4FD98-048A-4BD7-A31E-0414B0D8A6CBQ28344150-F95068E8-3C69-475C-A053-D77F78418F88Q28363489-0450F1D5-5610-4086-A608-9BAAA7263041Q28363810-399A2A59-50B7-410D-9EB4-94C01D9B6240Q28506217-AFEC5DA5-68AC-47AA-AF8C-346C5776DE36Q28506509-3FA0AFA2-4C30-423E-93E5-F3129CE3FFEDQ28511467-829C6150-F725-42A7-B50D-0CC3FB63DF76Q28535016-2D2D3E8D-CA0D-4FB4-8523-A23B70335F55Q28569337-79B22C00-75C0-483D-8B30-8CF5CAEF497CQ28579200-22F90B7D-A98A-4251-8C26-161E2434728EQ28579972-537F2902-ED0B-4B9A-B584-57A10206CAE0Q28592498-DA381A72-A782-4B81-9FA8-D598BD9F1AE6Q30373731-7684BC88-D106-4E8B-8834-E51E35F25FFAQ30979037-165206E1-070D-4B51-9FE1-EA864F95C4A5Q32066326-9A14F808-E2FA-47D1-9636-D02FD132EC13Q33269953-EADA3737-E451-4396-8A72-C0D15150DF8AQ33577563-FCAD5FBD-B3DD-4916-B48C-F75EB7E85F26Q33585657-5985DB79-8CDD-4E08-8F77-174F03EA523EQ33589194-20AEEB3E-28A7-482F-9F5E-5D49081FB575Q33620325-BC09CA23-1FF2-498C-8F87-166866702878Q33679873-47B20F51-8C87-4944-A231-D0D4A5B46CC0Q33739088-DE79DECD-B93A-4571-A01D-A772FB03C007Q33825419-818EB26E-081E-4987-9C3D-2F69B5AF103DQ33870204-B702F8A7-A2B6-4650-9102-EF543A8D7C4C
P2860
The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
name
The Tangier disease gene produ ...... mediated lipid removal pathway
@ast
The Tangier disease gene produ ...... mediated lipid removal pathway
@en
The Tangier disease gene produ ...... mediated lipid removal pathway
@en-gb
The Tangier disease gene produ ...... mediated lipid removal pathway
@nl
type
label
The Tangier disease gene produ ...... mediated lipid removal pathway
@ast
The Tangier disease gene produ ...... mediated lipid removal pathway
@en
The Tangier disease gene produ ...... mediated lipid removal pathway
@en-gb
The Tangier disease gene produ ...... mediated lipid removal pathway
@nl
prefLabel
The Tangier disease gene produ ...... mediated lipid removal pathway
@ast
The Tangier disease gene produ ...... mediated lipid removal pathway
@en
The Tangier disease gene produ ...... mediated lipid removal pathway
@en-gb
The Tangier disease gene produ ...... mediated lipid removal pathway
@nl
P2093
P2860
P3181
P356
P1476
The Tangier disease gene produ ...... mediated lipid removal pathway
@en
P2093
A M Vaughan
J G Porter
J J Seilhamer
K Schwartz
P2860
P304
P3181
P356
10.1172/JCI8119
P407
P50
P577
1999-10-01T00:00:00Z